
Women’s Health Initiative
The Challenge: This has resulted in a general underrepresentation and lack of focus on women’s health. Not understanding and studying these nuances impacts not only patients, but also employers and the healthcare system.

The application period will run from Sept. 23 – Dec. 6, 2024 at 1 p.m. EST.
Funding Inequities in Women's Health Research
50-75%
more likely than men to have an adverse drug reaction across all therapeutic indications [3].
of drugs that have been pulled from the market over safety concerns are due to adverse effects specifically in women.

Working Toward Solutions
While some progress has been made, from increased female participation in clinical trials to women’s health in general being better defined, more work remains [4].
The MLSC aims to support and incentivize translational project teams developing novel solutions in this area of need. The Center’s Women’s Health Initiative strives to turn the tide against the severe lack of organized capital and incentives around a coordinated Women’s Health approach.
With continued strategic investment in this area, Massachusetts is poised to become the leader in the Women’s Health space.
Our Focus
The MLSC launched its Women’s Health Initiative in 2020 to support efforts which increase understanding of sex and gender differences in biology (that has translational potential) or developing solutions for diseases or conditions that affect women solely, disproportionately, or differently.
The MLSC has deployed more than $19 million across 60 projects in collaboration with 15 companies, fostering advancements in translational research.

invested by the MLSC

in follow-on funding received

supported
Our Focus
The MLSC launched its Women’s Health Initiative in 2020 to support efforts which increase understanding of sex and gender differences in biology (that has translational potential) or developing solutions for diseases or conditions that affect women solely, disproportionately, or differently.
The MLSC has deployed more than $19 million across 60 projects in collaboration with 15 companies, fostering advancements in translational research.
invested by the MLSC to support


in follow-on funding received
Our Focus
The MLSC launched its Women’s Health Initiative in 2020 to support efforts which increase understanding of sex and gender differences in biology (that has translational potential) or developing solutions for diseases or conditions that affect women solely, disproportionately, or differently.
The MLSC has deployed more than $19 million across 60 projects in collaboration with 15 companies, fostering advancements in translational research.
Deployed more than
in projects that factor advancements in transitional research


Deployed funds across
in collaboration with
Building a Women’s Health Pipeline

“Innovation is Massachusetts’ calling card now and into the future. The Mass Leads Act doubles down on our leadership opportunities in areas like women’s health to advance not only our life sciences sector, but also our health care system and broader economy.”
– Lieutenant Governor Kim Driscoll

“This funding will allow for the establishment of a state-of-the art center to study lactation science. The Lactation Lab will encompass both a basic science laboratory, with protocols optimized for breastmilk assays, and a clinical research space designed for the needs of breastfeeding women and their infants.”
– Sarbattama Sen, MD, Vice Chair of Pediatric Research, Women and Infants Hospital of Rhode Island and Former Attending Neonatologist, Brigham and Women’s Hospital
“Massachusetts has already established the infrastructure, supported by the MLSC, to leverage new investments in women’s health to maximize the impact. The MLSC serves as an example of the impact that investment in women’s health can provide.”
– Jamie Maguire, Professor at Tufts University School of Medicine
[2] Mirin, A. Gender Disparity in the Funding of Diseases by the U.S. National Institutes of Health. Journal of Women’s Health 2021 30:7, 956-963
[3] Tharpe, N. Adverse drug reactions in women’s health care. J Midwifery Womens Health. 2011 56(3):205-13. PMID: 21535369.
[4] Vasquez-Avila, K. Addressing the critical role of gender identity and sex in the planning, analysis, and conduct of clinical trials. Princ Pract Clin Res. 2021;7(2):59-62. PMID: 34532571.
Connect with us to learn more
Other Programs

